Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Price History  |  Ratios  |  Insiders

Stock Quote Today & Recent News Legend Biotech Corporation LEGN

Healthcare Biotechnology
Legend Biotech Corporation, through its subsidiaries, operates as a biopharmaceutical company that discovers, develops, manufactures, and commercializes novel cell therapies for oncology and other indications in the United States, China, and Europe. Its lead product candidate is ciltacabtagene autoleucel, or cilta-cel, which is a chimeric antigen receptor (CAR-T) therapy for the treatment of... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:LEGN)

Legend Biotech to Present CARVYKTI® Data at 2026 Tandem Meetings Reinforcing Growing Evidence Supporting Earlier Use

GlobeNewswire January 21, 2026

Legend Biotech Highlights Recent Business Updates at 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire January 12, 2026

Legend Biotech to Present at the 44th Annual J.P. Morgan Healthcare Conference

GlobeNewswire December 17, 2025

Legend Biotech Highlights New CARVYKTI® Data in Multiple Myeloma and First-in-Human Results from Novel CAR-T Platform in Non-Hodgkin Lymphoma at ASH 2025

GlobeNewswire December 6, 2025

Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia

GlobeNewswire November 13, 2025

Legend Biotech Reports Third Quarter 2025 Results and Recent Highlights

GlobeNewswire November 12, 2025

Legend Biotech Announces 10 Presentations at the 67th American Society of Hematology (ASH) Annual Meeting

GlobeNewswire November 3, 2025

Legend Biotech to Host Investor Conference Call on Third Quarter 2025 Results

GlobeNewswire October 29, 2025

Legend Biotech to Participate in the Morgan Stanley Global Healthcare Conference

GlobeNewswire August 26, 2025
View More News ››

Opinion & Analysis (NDAQ:LEGN)

No current opinion is available.
View More Opinion ››

Bullboard Posts (NDAQ:LEGN)

LEGN Investors?

LEGN is on a roll and I've been accumulating. Anyone else interested in this stock and want to keep up with the latest?
garden555 - July 9, 2025
View more Bullboard ››

Walker Lane Resources Ltd.

Walker Lane Resources Ltd.

Walker Lane Resources Ltd. engages in the acquisition and exploration of mineral properties in Canada. The company explores ...
View More »

Podcasts